Skip to main content
. 2011 Jun 14;6(1):44–51. doi: 10.1111/j.1750-2659.2011.00266.x

Table 2.

 Primary diagnoses for emergency department visit or hospitalization within 42 days after LAIV vaccination

Event Events* Among LAIV‐Vaccinated Women, n Proportion of LAIV‐vaccinated women with ED visit or hospitalization, %, (95% CI)
ED visit Hospitalization ED visit or hospitalization
Any complication 5 3 8 5·8 (2·5–11·1)
Obstetrical complications
 Any 0 2 2 1·4 (0·2–5·1)
 643·13 – Hyperemesis gravidarum with metabolic disturbance, antepartum 0 1 1 0·7 (0·02–4·0)
 644·03 – Threatened premature labor, without delivery 0 1 1 0·7 (0·02–4·0)
Cardiopulmonary conditions
 Any 1 0 1 0·7 (0·02–4·0)
 466·0 – Acute bronchitis 1 0 1 0·7 (0·02–4·0)
Other conditions
 Any 4 1 5 3·6 (1·2–8·3)
 590·80 – Pyelonephritis, unspecified 0 1 1 0·7 (0·02–4·0)
 789·06 – Epigastric symptoms involving abdomen and pelvis 1 0 1 0·7 (0·02–4·0)
 729·5 – Pain in limb 1 0 1 0·7 (0·02–4·0)
 787·91 – Diarrhea 1 0 1 0·7 (0·02–4·0)
 786·59 – Chest pain; other 1 0 1 0·7 (0·02–4·0)

ED, emergency department; LAIV, live attenuated influenza vaccine.

*Excludes visits for delivery. Each woman could contribute only one ED visit and one hospitalization per ICD‐9 code.